Completed EARLY_PHASE1 INTERVENTIONAL 4-arm NCT02233647

Phendimetrazine and Cocaine

Safety and Tolerability of Cocaine During Phendimetrazine Maintenance

Sponsor: National Institute on Drug Abuse (NIDA)

Updated 7 times since 2017 Last updated: Sep 26, 2017 Started: Sep 30, 2014 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This EARLY_PHASE1 trial investigates Cocaine Use Disorder and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1
May 2017 — Jun 2018 [monthly]

Completed EARLY_PHASE1

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Completed EARLY_PHASE1

Phase: Phase 0 → EARLY_PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed Phase 0

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
William Stoops

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lexington, United States